MR spectroscopy can be used to assess the metabolic status of elite athletes' muscle fibers. This type of metabolic information might be useful for assessing training conditions or revealing individual predispositions to particular types of muscular
MR spectroscopy can be used to assess the metabolic status of elite athletes' muscle fibers. This type of metabolic information might be useful for assessing training conditions or revealing individual predispositions to particular types of muscular activity, according to research presented Friday at the ECR.
Dr. Roberto Pastorino and colleagues from the department of experimental medicine at the University of Genoa, Italy, used phosphorus MR spectroscopy to analyze the concentrations of quadriceps muscle metabolites in elite track and field athletes trained in long-distance and sprint running.
The researchers measured adenosine triphosphate (ATP), phosphocreatine (PCr), and inorganic phosphate (Pi) and their reciprocal ratio in 27 athletes, whose ages ranged between 18 and 35. Fifteen subjects were sprint runners, five were middle-distance runners, and seven were long-distance or marathon runners.
MRS was performed with a heart-liver spectroscopy coil and spin-echo sequences for a 2D-CSI technique, characterized by repetition times of 323 msec and echo times of 3 msec, with a total acquisition time of nearly 17 minutes.
The mean value of PCr/ATP measured in sprint runners was 3.2, while PCr/ATP in long-distance runners was 4.2. Other metabolites did not show any agreement with the running specialty. This disparity between long-distance runners and sprinters might be indicative of fiber type differences developed by good training, Pastorino said.
"Phosphocreatine is more present in long-distance runners because they process their energy differently from sprinters, who use a higher metabolism without lactic acid protection," he said.
ECR Study Finds Mixed Results with AI on Breast Ultrasound
March 6th 2024While adjunctive use of AI led to significantly higher specificity and accuracy rates in detecting cancer on breast ultrasound exams in comparison to unassisted reading by breast radiologists, researchers noted that 12 of 13 BI-RADS 3 lesions upgraded by AI were ultimately benign, according to research presented at the European Congress of Radiology.
Can Autonomous AI Help Reduce Prostate MRI Workloads Without Affecting Quality?
March 1st 2024Based on findings from a multicenter study of over 1,600 patients, researchers at the European Congress of Radiology suggest the inclusion of autonomous artificial intelligence (AI) triage could facilitate up to a 75 percent reduction in prostate MRI reading workload.
Five Insights on Artifacts and Limitations with Contrast-Enhanced Mammography
February 29th 2024Noting that technique issues, patient positioning miscues and atypical features can all contribute to faulty interpretation with contrast-enhanced mammography (CEM), researchers at the European Congress of Radiology shared their insights on navigating artifacts and limitations with CEM.
ECR Study Examines Key Predictive Factors for Metastasis in Patients with High-Risk Prostate Cancer
February 28th 2024Sixty-five percent of patients with newly diagnosed high-risk prostate cancer may have extraprostatic extension on MRI, and PSMA PET/CT findings suggest those with Gleason scores of eight or higher have more than double the risk of metastasis, according to a new study presented at the European Congress of Radiology (ECR).